$13 Million Grant to Study Malignant Brain Tumors Awarded to YSPH Researcher and Colleagues
A team of scientists led by researchers at the Yale School of Public Health has received a $13 million grant to investigate the molecular evolution of lower grade gliomas, slow growing but malignant brain tumors that primarily affect young adults.
$8.5M Federal Grant Aims for Big Impact from Small Molecules in the Gut
Yale researchers across a range of disciplines are coming together to explore the important role of microbial metabolites in our microbiota—the trillions of bacterial cells that colonize our intestines.Source: Yale West Campus
Breaking it Down: How the Chemistry of Digestion is Uncovering Sex-Specific Causes of Colon Cancer
A new technology called metabolomics allows researchers to explore the small chemicals formed and used during digestion as a window into the formation of diseases such as colon cancer, seeking early warning signs and potent tactics for prevention.
Neuroscientists, Geneticist Win ‘High Risk, High Reward’ Grants
Three Yale researchers have won 2018 ‘High Risk, High Rewards’ grants from the Common Fund of the National Institutes of Health, which intends to fund “major opportunities and gaps in biomedical research that require trans-NIH collaboration to succeed.”
Yale Cancer Center receives $1 million grant to address cancer disparities
Researchers at Yale Cancer Center (YCC) have been awarded a $1 million grant by the Bristol-Myers Squibb Foundation (BSMF) to address health care disparities in cancer care and support. The grant will fund the Cancer Disparities Firewall project, a multilevel intervention that focuses on patient and system level factors that contribute to cancer disparities in the YCC/New Haven, Connecticut area. The project will target lung, breast, colorectal, and prostate cancer.
Can Digestive Chemistry Uncover Sex-Specific Causes of Colon Cancer?
Dr. Caroline Helen Johnson received this year’s Wendy U. and Thomas C. Naratil Pioneer Award and co-funding from the Yale Cancer Center to explore hormones and environmental factors related to metabolite production (such as sugars and amino acids) and beneficial bacteria that live in the colon as possible sources of gender difference.
$1.8 Million Granted to Yale School of Public Health to Study Effectiveness of HPV Vaccine
A $1.8 million National Institutes of Health grant will help researchers at the Yale School of Public Health shed light on the real-world effectiveness of the Human Papillomavirus (HPV) vaccine. Results of this study can ultimately help to maximize the vaccine’s impact on several types of cancer.
Blavatnik Fund awards grants for innovation
Several faculty members won research grants from the Blavatnik Fund for Innovation at Yale at the fourth annual Yale Innovation Summit on May 10. The summit, presented by the Office of Cooperative Research (OCR) and Yale Entrepreneurial Institute, provides a window into an expanding entrepreneurial ecosystem at Yale.
American Cancer Society Approves New Research and Training Grants at Yale University
The American Cancer Society (ACS), the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University. These grants are among 11 new projects in effect across New England as of January 1, 2017 totaling more than $4.4 million dollars.
New federally funded program energizes lung cancer research
Armed with an $11 million grant from the National Cancer Institute (NCI), Yale Cancer Center and Smilow Cancer Hospital at Yale New Haven will launch a new research program in non-small cell lung cancer (NSCLC), one of the world’s most prevalent and lethal forms of cancer.Source: Medicine @ Yale
Center provides researchers access to highly specialized tools
If a researcher needs highly the specialized expertise and equipment required to investigate a blood disease, where does she go? Answer: the Yale Cooperative Center of Excellence in Hematology Specialized Core Center (YCCEH). The National Institutes of Health has designated Yale as one of three universities nationwide to receive a $5 million, five-year grant. The others include the University of Washington and Indiana University.
Yale Cancer Center wins grant to improve care for metastatic breast cancer patients
A proposal for improving the partnership between metastatic breast cancer patients and their medical care teams has garnered Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven a $358,000 award from the National Comprehensive Cancer Network (NCCN) in collaboration with Pfizer. Only ten awards were given to cancer centers around the country.
Five Yale researchers awarded grants to study women’s reproductive cancers
Five researchers from the Yale School of Medicine have received grants from Discovery to Cure, a program at the Department of Obstetrics, Gynecology, and Reproductive Sciences that advances the prevention, early detection, and treatment of women’s reproductive cancers such as ovarian, uterine, cervical, vaginal, and vulvar cancers.
Mutation Mystery: A Clinician Seeks Answers to Improve Skin Cancer Treatment for Women
Dr. Christine Ko has launched a study to see if a mutated gene can serve as a biological marker to predict the growth rate and recurrence of squamous cell carcinoma, a type of tumor of the thin outer layer of skin that affects about 700,000 Americans each year.